Tegria News and Activities

Tegria is owned by Altaris. Altaris has a direct presence in 2 countries.

Altaris has 9 subsidiaries including Analogic, Kindeva Drug Delivery and Minaris Advanced Therapies.

They are in:

• Pharmaceuticals40%
• Healthcare20%
• Other40%

Acquisition, funding and merger involving Altaris.

• Altaris has acquired Sharecare (posted on June 21 2024).

View the org chart displaying its 8 main executives

Most searched biographies at Tegria

• Craig Mengert, Chief Executive Officer
• Brian Cahill, Independent Director
• Andrea Corona, Managing Director, Transformation and Strategy

Popular executive movements at Tegria

• Craig Mengert has joined the company as Chief Executive Officer  (posted on June 11 2026).
• Brian Cahill who was Chief Executive Officer, becomes Independent Director  (posted on June 11 2026).

Popular executive movements at Altaris

• Dorothy Sandberg has joined the company as Vice President, Human Resources and Talent Development  (posted on October 20 2025).

Create your alert
to follow the executive moves at Tegria.

Altaris has 3,548 competitors including UnitedHealth Group (United States (USA)), Kaiser Permanente (United States (USA)) and HCA (United States (USA)).

Popular M&A news in Healthcare

• Vizient has acquired Empierus (posted on June 12 2026).
• Novanta has announced the acquisition of Riverpoint Medical  (posted on June 10 2026).
• Photocure has announced the acquisition of Vesica Health  (posted on June 8 2026).

Popular contacts in Healthcare

• Ari Bousbib - Chairman and Chief Executive Officer at IQVIA
• Dan Rice - Board Member at Adobe Population Health
• Gregory Adams - Chief Executive Officer and Chairman of the Board at Kaiser Permanente

Learn more about the Healthcare industry

Press releases by Tegria

Social media about Tegria

• Tegria on Wikipedia, Google News & Yahoo Finance
• Tegria on LinkedIn, X (Twitter) & YouTube